Cancer Diagnostics & Research Solutions | Revvity

US

Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

Republic of Korea *

cancer-1077x606

A cancer cell is unique from its genetic makeup to its microenvironment. Molecular diagnostics can be leveraged to screen a tumor’s molecular profile delivering information to support the identification of the right target - for the right individual, at the right dose, and at the right time. This is based on biomarkers identified by analyzing a tumor’s genome (DNA) or transcriptome (mRNA). The integration of this information can provide a detailed molecular picture of tumors and improve the likelihood that individuals will benefit from treatment.

We offer innovative, end-to-end workflows for biomarker identification and characterization as well as applications that enable labs to translate insights into decisions rapidly and efficiently. Adaptable and scalable solutions allow labs to minimize errors, reduce hands-on time, and increase throughput and reproducibility. Flexible modules, based on your testing and throughput requirements, can be used to meet your lab’s current and future needs.

Explore our cancer clinical solutions

HPV Testing

The EUROArray HPV enables detection and typing of 30 genital human papillomaviruses, especially valuable in the framework of cervical carcinoma screening.

ASR Flow Cytometry Antibodies

Our ASR antibodies, polyclonal/monoclonal, antigens of clinical interest. Intended for clinical/clinical research to identify/quantify a substance in specimens.

View all View less

Products may not be licensed in accordance with the laws in all countries, such as the United States and Canada. Please check with your local representative for availability.

Analyte Specific Reagents (ASR): Analytical and performance characteristics are not established.

Explore our cancer research solutions

ctDNA Workflows

See our complete workflows which can simplify and improve the efficiency of your cell free tumor (ctDNA) research using liquid biopsies.

miRNA-seq Analysis

Small RNA target discovery has never been so easy with our gel-free workflow optimized to reduce bias and increase miRNA discovery even with low input samples.

Exosome & cfRNA Analysis

Simplify your exosome and cfRNA research with a complete miRNAseq workflow from exoRNA delivering a high number of reads aligning to mature miRNA and low adapter dimers.

Targeted Sequencing

Complete, single-source target capture workflows enable cancer research by improving the efficiency of germline mutation identification.

Single Cell Sequencing

Explore our innovative single cell RNA-seq solutions revolutionizing the understanding of the biological characteristics and dynamics within cancerous tumors.

Mimix Reference Standards

Take control of your assay workflow with patient-like quality controls for large panel NGS, liquid biopsy-based assays and cancer-specific testing.

Functional Testing

Examine the cellular response to drug exposure on live tissues to guide the right course of treatment, complementing your genomics-based approaches.

BiomarkerDiscovery-512x288

Biomarker Discovery

Biomarkers are biological indicators, such as genes, proteins, or other measurable biological characteristics, that can be used to detect, diagnose, or monitor various diseases and health conditions.

View all View less

For research use only. Not for use in diagnostic procedures.

Featured resources

Application Note

Inhibition of FGFR signaling pathways studied in cancer cell lines using HTRF

Unraveling the power of unique molecular identifiers in cancer research.

Challenges in analyzing data with UMI-UDIs in next-generation sequencing

Biomarker discovery solutions

Biomarker discovery solutions flyers

Featured blogs

Real-time hypoxia monitoring using live cell imaging.

Real-time live cell imaging allows dynamic monitoring of tumor hypoxia and reoxygenation to optimize KORTUC radiosensitization therapy timing.

Elucidating critical anti-tumor immunity pathways via imaging-based cytotoxicity assays.

Imaging Cytometry is a Highly Useful Tool for In vitro T cell Immunology Studies

Quantifying CAR T-cell mediated tumor killing using image-based cytometry.

The Celigo image cytometer provided unbiased, quantitative data to evaluate CAR T-cell efficacy in a humanized model of ccRCC

How conditional bispecific antibodies are advancing precision immunotherapy.

Conditional bispecific antibodies improve cancer immunotherapy by targeting tumors precisely, enhancing efficacy and safety through localized immune activation.

Scaling up oligonucleotide discovery: accelerating therapeutic lead identification from months to weeks.

Read how to scale up oligonucleotide discovery and accelerate therapeutic lead identification from months to weeks in this informative blog post from Revvity.

Good gut feelings about the health of microbial research.

Microbial research and metagenomics in laboratories – perspectives from a researcher on microbiome in cancer and antimicrobial resistance.

Clonal cell lines or pool cell populations? Choosing the right solution to help avoid inconsistent results.

Choosing between clonal cell lines and pool cell populations to help limit inconsistent results.

Happy birthday Cellometer Ascend – and Q&A with Charles Hernandez.

Happy birthday Cellometer Ascend – and Q&A with Charles Hernandez.